NCT05507528View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

November 11, 2023

Study Completion Date

November 11, 2023

Conditions
LIPOLYSIS
Interventions
DEVICE

reborn treatment

Fat reduction treatments with the ReBorn LED System visit - include the treatment procedure

Trial Locations (3)

37215

Tennessee Clinical Research Center, Tennessee City

49100

rabin medical center - campus Hasharon, Petah Tikva

3501261

Herzelia Medical Center - Tal Nachliely clinic, Kiryat Bialik

All Listed Sponsors
lead

Lightfective Ltd

INDUSTRY